Skip Header Navigation

 Nitric Oxide Research in the
  Laboratory of Comparative Carcinogenesis
          - Chemistry Section -

Home

Diazeniumdiolates for
Research and Potential /
Clinical Applications


Group Members

News News RSS Icon


How can we
help your research?
Contact us at
keefer@ncifcrf.gov
Phone: (301)-846-1467
Fax    : (301)-846-5946



Related Links:
LCC Homepage

NCI Center for
Cancer Research


NCI-Frederick

PROLI/NO Derivatives

The diazeniumdiolate anion of L-proline, PROLI/NO, spontaneously dissociates under physiological conditions to release nitric oxide with a half-life of 2 s. A minor byproduct of nitric oxide release from PROLI/NO is N-nitrosoproline (NPRO), which has shown no carcinogenic activity in several animal models. Thus, this aspect of innocuous byproduct formation makes PROLI/NO an attractive nitric oxide prodrug from the clinical standpoint.

PROLINO_derivatives_gif

Related Publications

Chakrapani, H.; Showalter, B. M.; Kong, L.; Keefer, L. K.; Saavedra, J. E. Organic Letters 2007, 19, 3409-3412.

Waterhouse, D. J.; Saavedra, J. E.; Davies, K. M.; Citro, M. L.; Xu, X.; Powell, D. A.; Grimes, G. J.; Potti, G. K.; Keefer, L. K. J. Pharm. Sci. 2006,95, 108-115.

Champion, H. C.; Bivalacqua, T. J.; Wang, R.; Kadowitz, P. J.; Keefer, L. K.; Saavedra, J. E.; Hrabie, J. A.; Doherty, P. C.; Hellstrom, W. J. G. J. Urol. 1999, 161, 2013-2019.

Saavedra, J. E.; Southan, G. J.; Davies, K. M.; Lundell, A.; Markou, C.; Hanson, S. R.; Adrie, C.; Hurford, W. E.; Zapol, W. M.; Keefer, L. K. J. Med. Chem. 1996, 39, 4361-4365.